Annual CFI
-$6000.00
+$1000.00+14.29%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual cash flow from investing activities is -$6000.00, with the most recent change of +$1000.00 (+14.29%) on December 31, 2023.
- During the last 3 years, CYCC annual CFI has risen by +$90.00 thousand (+93.75%).
- CYCC annual CFI is now -100.02% below its all-time high of $27.34 million, reached on December 31, 2008.
Performance
CYCC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, CYCC quarterly CFI has stayed the same.
- CYCC quarterly CFI is now -100.00% below its all-time high of $10.59 million, reached on June 30, 2008.
Performance
CYCC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, CYCC TTM cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, CYCC TTM CFI has increased by +$6000.00 (+100.00%).
- CYCC TTM CFI is now -100.00% below its all-time high of $27.34 million, reached on December 31, 2008.
Performance
CYCC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CYCC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.3% | 0.0% | +100.0% |
| 3 y3 years | +93.8% | +100.0% | +100.0% |
| 5 y5 years | +84.6% | +100.0% | +100.0% |
CYCC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.8% | at high | +100.0% | -100.0% | +100.0% |
| 5 y | 5-year | -121.4% | +93.8% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Cyclacel Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2023 | -$6000.00(-14.3%) | $0.00(0.0%) | -$6000.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | -$6000.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) | -$6000.00(-33.3%) |
| Mar 2023 | - | -$6000.00(<-9900.0%) | -$9000.00(+28.6%) |
| Dec 2022 | -$7000.00(-74.1%) | $0.00(0.0%) | -$7000.00(-22.2%) |
| Sep 2022 | - | $0.00(-100.0%) | -$9000.00(-50.0%) |
| Jun 2022 | - | -$3000.00(-25.0%) | -$18.00 K(-138.3%) |
| Mar 2022 | - | -$4000.00(+100.0%) | $47.00 K(-274.1%) |
| Dec 2021 | -$27.00 K(-71.9%) | -$2000.00(-77.8%) | -$27.00 K(-59.7%) |
| Sep 2021 | - | -$9000.00(-114.5%) | -$67.00 K(-38.0%) |
| Jun 2021 | - | $62.00 K(-179.5%) | -$108.00 K(-36.5%) |
| Mar 2021 | - | -$78.00 K(+85.7%) | -$170.00 K(+77.1%) |
| Dec 2020 | -$96.00 K(-442.9%) | -$42.00 K(-16.0%) | -$96.00 K(+100.0%) |
| Sep 2020 | - | -$50.00 K(<-9900.0%) | -$48.00 K(+2300.0%) |
| Jun 2020 | - | $0.00(-100.0%) | -$2000.00(-33.3%) |
| Mar 2020 | - | -$4000.00(-166.7%) | -$3000.00(-110.7%) |
| Dec 2019 | $28.00 K(-171.8%) | $6000.00(-250.0%) | $28.00 K(+75.0%) |
| Sep 2019 | - | -$4000.00(+300.0%) | $16.00 K(-11.1%) |
| Jun 2019 | - | -$1000.00(-103.7%) | $18.00 K(+80.0%) |
| Mar 2019 | - | $27.00 K(-550.0%) | $10.00 K(-125.6%) |
| Dec 2018 | -$39.00 K(+200.0%) | -$6000.00(+200.0%) | -$39.00 K(+11.4%) |
| Sep 2018 | - | -$2000.00(-77.8%) | -$35.00 K(-16.7%) |
| Jun 2018 | - | -$9000.00(-59.1%) | -$42.00 K(+27.3%) |
| Mar 2018 | - | -$22.00 K(+1000.0%) | -$33.00 K(+153.8%) |
| Dec 2017 | -$13.00 K(-244.4%) | -$2000.00(-77.8%) | -$13.00 K(+550.0%) |
| Sep 2017 | - | -$9000.00(<-9900.0%) | -$2000.00(-128.6%) |
| Jun 2017 | - | $0.00(-100.0%) | $7000.00(0.0%) |
| Mar 2017 | - | -$2000.00(-122.2%) | $7000.00(-22.2%) |
| Dec 2016 | $9000.00(-85.5%) | $9000.00(>+9900.0%) | $9000.00(-87.3%) |
| Sep 2016 | - | $0.00(0.0%) | $71.00 K(+16.4%) |
| Jun 2016 | - | $0.00(0.0%) | $61.00 K(+15.1%) |
| Mar 2016 | - | $0.00(-100.0%) | $53.00 K(-14.5%) |
| Dec 2015 | $62.00 K(-17.3%) | $71.00 K(-810.0%) | $62.00 K(-22.5%) |
| Sep 2015 | - | -$10.00 K(+25.0%) | $80.00 K(-256.9%) |
| Jun 2015 | - | -$8000.00(-188.9%) | -$51.00 K(-368.4%) |
| Mar 2015 | - | $9000.00(-89.9%) | $19.00 K(-74.7%) |
| Dec 2014 | $75.00 K(-98.7%) | $89.00 K(-163.1%) | $75.00 K(+733.3%) |
| Sep 2014 | - | -$141.00 K(-327.4%) | $9000.00(-93.7%) |
| Jun 2014 | - | $62.00 K(-4.6%) | $143.00 K(-97.5%) |
| Mar 2014 | - | $65.00 K(+182.6%) | $5.71 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $5.69 M(>+9900.0%) | $23.00 K(-428.6%) | $5.69 M(+0.4%) |
| Sep 2013 | - | -$7000.00(-100.1%) | $5.67 M(-0.1%) |
| Jun 2013 | - | $5.63 M(>+9900.0%) | $5.67 M(+7460.0%) |
| Mar 2013 | - | $40.00 K(>+9900.0%) | $75.00 K(+50.0%) |
| Dec 2012 | $50.00 K(-5100.0%) | $0.00(-100.0%) | $50.00 K(-9.1%) |
| Sep 2012 | - | -$2000.00(-105.4%) | $55.00 K(+7.8%) |
| Jun 2012 | - | $37.00 K(+146.7%) | $51.00 K(+264.3%) |
| Mar 2012 | - | $15.00 K(+200.0%) | $14.00 K(-1500.0%) |
| Dec 2011 | -$1000.00(-103.0%) | $5000.00(-183.3%) | -$1000.00(<-9900.0%) |
| Sep 2011 | - | -$6000.00(<-9900.0%) | $0.00(-100.0%) |
| Jun 2011 | - | $0.00(0.0%) | $6000.00(+100.0%) |
| Mar 2011 | - | $0.00(-100.0%) | $3000.00(-90.9%) |
| Dec 2010 | $33.00 K(-97.9%) | $6000.00(>+9900.0%) | $33.00 K(-60.7%) |
| Sep 2010 | - | $0.00(-100.0%) | $84.00 K(+3.7%) |
| Jun 2010 | - | -$3000.00(-110.0%) | $81.00 K(-14.7%) |
| Mar 2010 | - | $30.00 K(-47.4%) | $95.00 K(-93.9%) |
| Dec 2009 | $1.56 M(-94.3%) | $57.00 K(-2000.0%) | $1.56 M(-78.2%) |
| Sep 2009 | - | -$3000.00(-127.3%) | $7.16 M(-17.1%) |
| Jun 2009 | - | $11.00 K(-99.3%) | $8.63 M(-55.1%) |
| Mar 2009 | - | $1.49 M(-73.6%) | $19.21 M(-29.7%) |
| Dec 2008 | $27.34 M(-220.5%) | $5.65 M(+283.1%) | $27.34 M(+0.4%) |
| Sep 2008 | - | $1.48 M(-86.1%) | $27.22 M(+42.6%) |
| Jun 2008 | - | $10.59 M(+10.1%) | $19.09 M(-211.2%) |
| Mar 2008 | - | $9.62 M(+73.8%) | -$17.18 M(-24.3%) |
| Dec 2007 | -$22.69 M(-680.2%) | $5.54 M(-183.2%) | -$22.69 M(-20.5%) |
| Sep 2007 | - | -$6.65 M(-74.1%) | -$28.56 M(-4.8%) |
| Jun 2007 | - | -$25.68 M(-725.3%) | -$30.01 M(-828.0%) |
| Mar 2007 | - | $4.11 M(-1352.1%) | $4.12 M(+5.4%) |
| Dec 2006 | $3.91 M(+42.5%) | -$328.00 K(-96.0%) | $3.91 M(-42.3%) |
| Sep 2006 | - | -$8.11 M(-195.9%) | $6.78 M(-6.4%) |
| Jun 2006 | - | $8.45 M(+116.9%) | $7.24 M(+77.5%) |
| Mar 2006 | - | $3.90 M(+53.6%) | $4.08 M(+48.6%) |
| Dec 2005 | $2.75 M(-110.2%) | $2.54 M(-133.2%) | $2.75 M(-126.2%) |
| Sep 2005 | - | -$7.64 M(-244.5%) | -$10.46 M(+199.3%) |
| Jun 2005 | - | $5.29 M(+106.4%) | -$3.49 M(-86.7%) |
| Mar 2005 | - | $2.56 M(-124.0%) | -$26.31 M(-2.1%) |
| Dec 2004 | -$26.87 M(-2297.4%) | -$10.67 M(+1471.1%) | -$26.87 M(+6.1%) |
| Sep 2004 | - | -$679.00 K(-96.1%) | -$25.34 M(+22.9%) |
| Jun 2004 | - | -$17.53 M(-976.0%) | -$20.61 M(-1373.9%) |
| Mar 2004 | - | $2.00 M(-121.9%) | $1.62 M(+32.3%) |
| Dec 2003 | $1.22 M | -$9.13 M(-325.6%) | $1.22 M(-88.2%) |
| Sep 2003 | - | $4.05 M(-13.9%) | $10.36 M(+64.2%) |
| Jun 2003 | - | $4.70 M(+192.7%) | $6.31 M(+292.7%) |
| Mar 2003 | - | $1.61 M | $1.61 M |
FAQ
- What is Cyclacel Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual CFI year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly CFI year-on-year change?
- What is Cyclacel Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals TTM CFI year-on-year change?
What is Cyclacel Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of CYCC is -$6000.00
What is the all time high annual CFI for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual cash flow from investing activities is $27.34 M
What is Cyclacel Pharmaceuticals annual CFI year-on-year change?
Over the past year, CYCC annual cash flow from investing activities has changed by +$1000.00 (+14.29%)
What is Cyclacel Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of CYCC is $0.00
What is the all time high quarterly CFI for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly cash flow from investing activities is $10.59 M
What is Cyclacel Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, CYCC quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Cyclacel Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of CYCC is $0.00
What is the all time high TTM CFI for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high TTM cash flow from investing activities is $27.34 M
What is Cyclacel Pharmaceuticals TTM CFI year-on-year change?
Over the past year, CYCC TTM cash flow from investing activities has changed by +$6000.00 (+100.00%)